title: Mucolytic activity of azelastine in mice and rats.
abstract: The mucolytic activity of azelastine, an antiallergic/antiasthmatic drug, in mice and rats was investigated. The oral administration of test compounds 30 min before phenol red i.p. injection stimulated dye secretion in the trachea of mice. The resulting oral ED50's (mg/kg) were: azelastine, 0.16; salbutamol, 2.5; N-acetylcysteine, 61.8; S-Carboxymethyl-l-cysteine, < 100; bromhexine, > 100; and potassium iodide, approximately 200. In rats, several drugs stimulated secretion of fluorescein sodium (FINa) in the tracheobronchial lumen. The resulting oral ED50's (mg/kg) were: azelastine, 0.33; terbutaline, 0.3; salbutamol, 0.89; and S-carboxymethyl-l-cysteine, 56.8. Terfenadine and diphenhydramine (1-10 mg/kg, p.o.) did not stimulate tracheal secretion in rats and mice. The mucolytic activity of azelastine may contribute to its overall effectiveness, including antitussive activity in asthmatics. Finally, this activity seems to be dissociated from its H1-histamine receptor blocking activity.
authors.affiliation: Wallace Laboratories, Division of Carter-Wallace, Inc., Cranbury, NJ 08512.
authors.forename: N
authors.initials: N
authors.lastname: Chand
authors.forename: J E
authors.initials: JE
authors.lastname: Harrison
authors.forename: S
authors.initials: S
authors.lastname: Rooney
authors.forename: W
authors.initials: W
authors.lastname: Diamantis
authors.forename: R D
authors.initials: RD
authors.lastname: Sofia
mesh_terms: D000111:Acetylcysteine / Q000008:administration & dosage / Q000494:pharmacology; D000284:Administration, Oral; D000420:Albuterol / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001964:Bromhexine / Q000008:administration & dosage / Q000494:pharmacology; D002233:Carbocysteine / Q000008:administration & dosage / Q000494:pharmacology; D004155:Diphenhydramine / Q000008:administration & dosage / Q000494:pharmacology; D005100:Expectorants / Q000494:pharmacology*; D019793:Fluorescein; D005452:Fluoresceins / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051379:Mice; D010637:Phenolsulfonphthalein / Q000378:metabolism; D010793:Phthalazines / Q000008:administration & dosage / Q000494:pharmacology*; D011193:Potassium Iodide / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D013726:Terbutaline / Q000008:administration & dosage / Q000494:pharmacology; D014132:Trachea / Q000187:drug effects* / Q000378:metabolism
chemical_list: D005100:Expectorants; D005452:Fluoresceins; D006634:Histamine H1 Antagonists; D010793:Phthalazines; D011193:Potassium Iodide; D002233:Carbocysteine; D004155:Diphenhydramine; D010637:Phenolsulfonphthalein; D013726:Terbutaline; D001964:Bromhexine; D000420:Albuterol; D019793:Fluorescein; D000111:Acetylcysteine; C020976:azelastine